| 1154 |
English |
Causality Assessment for ADR Reporting |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1155 |
English |
Causality Assessment: WHO-UMC [UPSALA Monitoring Centre] Causality Categories for ADR Reporting |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1156 |
English |
Severity Criteria for Reporting ADRs |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1157 |
English |
Interim Treatment Outcomes of DR-TB Cases |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1158 |
English |
Flow Chart of H Mono/Poly DR-TB Patients from Diagnosis to Treatment Outcome |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1159 |
English |
Flow Chart of MDR/RR-TB Patients on Shorter Oral Bedaquiline-containing Regimen from Diagnosis to Treatment Outcome |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1160 |
English |
Need for Palliative Care in DR-TB Patients |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1161 |
English |
Preventive Treatment for Contacts of DR-TB Patients: WHO Recommendations |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1162 |
English |
Quality Assurance of Anti-TB Drugs |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1163 |
English |
Universal Access to Quality TB Care |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1164 |
English |
End TB Strategy Approach |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1165 |
English |
Functions of District National Health Mission |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1166 |
English |
District TB Centre and its Functions |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1167 |
English |
Roles of Accredited Social Health Activist [ASHA] for TB Service Delivery at ABHWCs |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1168 |
English |
Recording and Reporting at Ayushman Bharat Health and Wellness Centres |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1169 |
English |
Patient Provider Support Agency [PPSA]: A Multipronged Approach to Engage the Private Sector |
Approved |
|
Archana.Singh |
Abhimanyu |
| 1170 |
English |
Importance of Properly Identifying Presumptive TB Cases |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1171 |
English |
Aims and Objectives of Screening for Active TB |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1172 |
English |
Precautions to Ensure Reliability of a Test for Diagnosis of DR-TB |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1173 |
English |
Duties and responsibilities of the LT at the DMC |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1174 |
English |
Formats used for monitoring [NTEP] |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1176 |
English |
Overview of the Patient Management Workflow in Nikshay |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1180 |
English |
Direct Benefits Transfer [DBT] Module: Nikshay Poshan Yojana [NPY] |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1181 |
English |
Nikshay TB Notification Report |
Approved |
|
Archana.Singh |
Abhimanyu |
| 1181 |
Marathi |
Nikshay TB Notification Report |
Approved |
|
Archana.Singh |
Abhimanyu |
| 1181 |
Telugu |
Nikshay TB Notification Report |
Approved |
|
Archana.Singh |
Abhimanyu |
| 1182 |
English |
Outcome Report |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1182 |
Marathi |
Outcome Report |
Published on LMS |
|
Archana.Singh |
Abhimanyu |
| 1182 |
Telugu |
Outcome Report |
Published on LMS |
|
Archana.Singh |
Abhimanyu |
| 1129 |
English |
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Pre-treatment Evaluation [PTE] |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1130 |
English |
Causes for Drug-resistant Tuberculosis |
Published on LMS |
|
Archana.Singh |
Abhimanyu |
| 1131 |
English |
Pre-treatment Counselling of DR-TB Patients |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1132 |
English |
Baseline Second-line Drug-susceptibility Testing |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1133 |
English |
Prevention of Drug-resistance |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1134 |
English |
Shorter oral Bedaquiline-containing MDR/RR-TB regimen |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1135 |
English |
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Treatment Extension |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1136 |
English |
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Eligibility Criteria |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1137 |
English |
Requirements from Institutions for the Establishment of Nodal DR-TB Centre |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1138 |
English |
DR-TB Services Referral Linkage Scenario 1: Patient Notified from the Private Sector |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1139 |
English |
DR-TB Service Referral Linkages Scenario 3: DR-TB Patient Referred for Treatment from the Private Sector with Bacteriological Confirmation in the Private Sector |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1140 |
English |
DR-TB Service Referral Linkages Scenario 5: DR-TB Patient Referred for Treatment from the Private Sector with Treatment Initiated in the Private Sector |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1141 |
English |
Rapid Molecular Drug-resistance Testing |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1142 |
English |
Clinical Monitoring of DR-TB Patients |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1143 |
English |
Use of M/XDR-TB Regimen in People Living with HIV [PLHIV] |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1144 |
English |
Pre-treatment Evaluation [PTE] in Longer Oral M/XDR-TB Regimen |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1145 |
English |
Use of Longer Oral M/XDR-TB Regimen in Severe Forms of Extrapulmonary TB and TB Meningitis |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1146 |
English |
Adverse Drug Reactions due to Longer oral M/XDR-TB Regimen |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1147 |
English |
Isoniazid [H] Mono/Poly DR-TB Regimen: Pre-treatment Evaluation |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1148 |
English |
Regimen, Duration and Dosage for Isoniazid [H] Mono/Poly DR-TB Regimen |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1149 |
English |
Replacement Sequence in the H Mono/Poly DR-TB and Shorter Oral Bdq-containing MDR/RR-TB Regimens |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |